journal article·2023-03Open access

Engineered Microparticles for Treatment of Murine Brain Metastasis by Reprograming Tumor Microenvironment and Inhibiting MAPK Pathway

Lisen Lu, Huaduan Zi, Jie Zhou, Jing Huang, Zihan Deng, Zijian Tang, Li Li, Xiujuan Shi, Pui‐Chi Lo, Jonathan F. Lovell, Deqiang Deng, Chao Wan, Honglin Jin

Advanced Science· Volume 10· Issue 8

Abstract

Abstract Brain metastases (BRM) are common in advanced lung cancer. However, their treatment is challenging due to the blood‐brain barrier (BBB) and the immunosuppressive tumor microenvironment (ITME). Microparticles (MPs), a type of extracellular vesicle, can serve as biocompatible drug delivery vehicles that can be further modulated with genetic engineering techniques. MPs prepared from cells induced with different insults are compared and it is found that radiation‐treated cell‐released microparticles (RMPs) achieve optimal targeting and macrophage activation. The enzyme ubiquitin‐specific protease 7 (USP7), which simultaneously regulates tumor growth and reprograms M2 macrophages (M2Φ), is found to be expressed in BRM. Engineered RMPs are then constructed that comprise: 1) the RMP carrier that targets and reprograms M2Φ; 2) a genetically expressed SR‐B1‐targeting peptide for improved BBB permeability; and 3) a USP7 inhibitor to kill tumor cells and reprogram M2Φ. These RMPs successfully cross the BBB and target M2Φ in vitro and in vivo in mice, effectively reprogramming M2Φ and improving survival in a murine BRM model. Therapeutic effects are further augmented when combined with immune checkpoint blockade. This study provides proof‐of‐concept for the use of genetically engineered MPs for the treatment of BRM.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Biomedicine and Health and College of Life Science and Technology Huazhong Agricultural University Wuhan 430070 P. R. China

Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 P. R. China

Beijing Institute of Clinical Research Beijing Friendship Hospital Capital Medical University Beijing 100050 P. R. China

Department of Biomedical Sciences City University of Hong Kong Tat Chee Avenue Kowloon Hong Kong HKG P. R. China

Department of Biomedical Engineering University at Buffalo State University of New York Buffalo NY 14260 USA

Funding

National Natural Science Foundation of China

References (58)

Show source-provided references
1. 10.3322/caac.2173110.3322/caac.21731 ↗
2. 10.1016/j.ejca.2020.03.00610.1016/j.ejca.2020.03.006 ↗
3. 10.1038/s41572-018-0055-y10.1038/s41572-018-0055-y ↗
4. 10.1200/JOP.19.0035710.1200/JOP.19.00357 ↗
5. 10.1155/2021/656458510.1155/2021/6564585 ↗
6. 10.1038/s41568-019-0224-710.1038/s41568-019-0224-7 ↗
7. 10.1038/ni.366610.1038/ni.3666 ↗
8. 10.1007/s11864-021-00911-710.1007/s11864-021-00911-7 ↗
9. 10.1038/s41573-022-00410-w10.1038/s41573-022-00410-w ↗
10. 10.1038/s41568-020-00299-w10.1038/s41568-020-00299-w ↗
11. 10.1002/advs.20200350510.1002/advs.202003505 ↗
12. 10.1038/8543810.1038/85438 ↗
13. 10.1002/advs.20190177910.1002/advs.201901779 ↗
14. 10.1126/scitranslmed.aba059910.1126/scitranslmed.aba0599 ↗
15. 10.1038/s41551-020-0583-010.1038/s41551-020-0583-0 ↗
16. 10.1158/2326-6066.CIR-19-078910.1158/2326-6066.CIR-19-0789 ↗
17. 10.1126/scitranslmed.aat569010.1126/scitranslmed.aat5690 ↗
18. 10.3389/fimmu.2020.0202410.3389/fimmu.2020.02024 ↗
19. 10.1002/advs.20220160910.1002/advs.202201609 ↗
20. 10.1158/2326-6066.CIR-14-017710.1158/2326-6066.CIR-14-0177 ↗
21. 10.1016/j.bioactmat.2021.07.01910.1016/j.bioactmat.2021.07.019 ↗
22. 10.1126/sciadv.aay978910.1126/sciadv.aay9789 ↗
23. 10.1016/j.jconrel.2017.12.01510.1016/j.jconrel.2017.12.015 ↗
24. 10.1002/advs.20200402510.1002/advs.202004025 ↗
25. 10.1016/j.biomaterials.2021.12088810.1016/j.biomaterials.2021.120888 ↗
26. 10.1016/j.neuron.2019.08.02810.1016/j.neuron.2019.08.028 ↗
27. Tomaszewski W. · Am. Assoc. Cancer Res. · 2019 · 25 · 4202
28. 10.1016/j.biomaterials.2021.12089110.1016/j.biomaterials.2021.120891 ↗
29. 10.1016/j.jconrel.2020.02.01110.1016/j.jconrel.2020.02.011 ↗
30. 10.1016/j.apsb.2022.02.00810.1016/j.apsb.2022.02.008 ↗
31. 10.1038/s41467-019-11911-510.1038/s41467-019-11911-5 ↗
32. 10.7150/thno.3071610.7150/thno.30716 ↗
33. 10.7150/thno.4713710.7150/thno.47137 ↗
34. 10.3389/fphar.2016.0046610.3389/fphar.2016.00466 ↗
35. 10.3389/fphys.2017.0084110.3389/fphys.2017.00841 ↗
36. 10.1016/j.biomaterials.2020.11998710.1016/j.biomaterials.2020.119987 ↗
37. 10.1172/JCI9422910.1172/JCI94229 ↗
38. 10.1089/dna.2011.123410.1089/dna.2011.1234 ↗
39. 10.1038/s41419-021-04363-710.1038/s41419-021-04363-7 ↗
40. 10.1021/acsnano.1c0550510.1021/acsnano.1c05505 ↗
41. 10.1016/j.nantod.2021.10132310.1016/j.nantod.2021.101323 ↗
42. 10.1016/j.biopha.2021.11140110.1016/j.biopha.2021.111401 ↗
43. 10.3390/cells1001010710.3390/cells10010107 ↗
44. 10.1038/s41422-022-00731-w10.1038/s41422-022-00731-w ↗
45. 10.1016/j.ijrobp.2022.06.09210.1016/j.ijrobp.2022.06.092 ↗
46. 10.7150/thno.4353910.7150/thno.43539 ↗
47. 10.1016/j.ymthe.2019.05.01610.1016/j.ymthe.2019.05.016 ↗
48. 10.1016/j.cell.2022.10.00610.1016/j.cell.2022.10.006 ↗
49. 10.1038/s41388-019-0971-710.1038/s41388-019-0971-7 ↗
50. 10.3389/fphar.2022.84162310.3389/fphar.2022.841623 ↗
51. 10.1016/j.cell.2022.09.02010.1016/j.cell.2022.09.020 ↗
52. 10.1038/s41568-019-0205-x10.1038/s41568-019-0205-x ↗
53. 10.1038/s41587-021-00972-x10.1038/s41587-021-00972-x ↗
54. 10.1038/s41467-020-19225-710.1038/s41467-020-19225-7 ↗
55. 10.1126/sciadv.abl587210.1126/sciadv.abl5872 ↗
56. 10.1016/j.ccell.2020.05.00210.1016/j.ccell.2020.05.002 ↗
57. 10.1038/s41586-019-1140-410.1038/s41586-019-1140-4 ↗
58. 10.1038/s41551-019-0485-110.1038/s41551-019-0485-1 ↗